-
1
Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
Gepubliceerd in 2025Onderwerpen: -
2
-
3
Supplementary Figure 4: RNA-sequencing in the primary AD-MSCs, BM-MSCs, and PSCs after treatment with KC and KCM serum
Gepubliceerd in 2025Onderwerpen: -
4
Supplementary Figure 6: Age-dependent differences in CAF activation
Gepubliceerd in 2025Onderwerpen: -
5
Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac
Gepubliceerd in 2025Onderwerpen: -
6
Data Sheet 1_The role of microRNAs and long non-coding RNAs in epigenetic regulation of T cells: implications for autoimmunity.pdf
Gepubliceerd in 2025Onderwerpen: -
7
-
8
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Gepubliceerd in 2025Onderwerpen: -
9
Supplementary Table S1 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
Gepubliceerd in 2025Onderwerpen: -
10
-
11
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Gepubliceerd in 2025Onderwerpen: -
12
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Gepubliceerd in 2025Onderwerpen: -
13
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Gepubliceerd in 2025Onderwerpen: -
14
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Gepubliceerd in 2025Onderwerpen: -
15
-
16
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Gepubliceerd in 2025Onderwerpen: -
17
-
18
-
19
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Gepubliceerd in 2025Onderwerpen: -
20